Parkinson's Blog

Gain Therapeutics reports positive early data from Parkinson’s trial

Scientists uncover how PP2A-B55α maintains brain energy balance and offers hope for Parkinson’s and mitochondrial diseases.

Sheelagh Wurr set up Salisbury Shakers after being diagnosed with an essential tremor in her 40s

In a groundbreaking development that could revolutionize the approach to neurodegenerative and mitochondrial diseases, researchers have identified a pivotal cellular mechanism governing energy balance and mitochondrial quality control. This discovery centers on phosphatase B55,

Currently, 15 other states use similar systems to help pinpoint risks.

Scientists have directly visualised alpha-synuclein oligomers in human brain tissue, a key trigger in Parkinson’s disease

UniSA researcher Deepa Nakmode’s work in managing Parkinson’s will go a long way in simplifying life for patients and caregivers

Key Takeaways

Parkinson’s Disease is the second most common neurological disorder but the fastest-growing, according to medical experts.

People have lots of misconceptions about Parkinson’s disease and how it develops, here are the facts…